(Q36802569)

16 August 2017

1 reference

title

Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia (English)

1 reference

16 August 2017

0 references

1 reference

James M McKenney

1

1 reference

PubMed ID

17461707

16 August 2017

Domenic Sica

series ordinal

2

1 reference

PubMed ID

17461707

16 August 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

16 August 2017

1 reference

16 August 2017

27

1 reference

16 August 2017

5

1 reference

16 August 2017

715-728

1 reference

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

16 August 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Issues in hyperlipidemic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Risk of adverse events with fibrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Effect of different antilipidemic agents and diets on mortality: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Fatty Acid Regulation of Gene Transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Alpha-linolenic acid metabolism in men and women: nutritional and biological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Usefulness of omega-3 fatty acids and the prevention of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

In contrast with docosahexaenoic acid, eicosapentaenoic acid and hypolipidaemic derivatives decrease hepatic synthesis and secretion of triacylglycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Study of the pharmacokinetic interaction between simvastatin and prescription omega-3-acid ethyl esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

Variable hypocoagulant effect of fish oil intake in humans: modulation of fibrinogen level and thrombin generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.5.715

21 January 2018

Identifiers

DOI

10.1592/PHCO.27.5.715

1 reference

16 August 2017

1 reference

PubMed ID

17461707